Icon

JALYN (nda022460)- (0.5MG;0.4MG)

DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE WAYLIS THERAP
0.5MG;0.4MG
Yes Yes
2015-Nov-20 Expired
None None
None No
JALYN is a combination of dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an alpha-adrenergic antagonist, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
2 0 2
Total Other Developers 2
Drugs with Suitability No
0.5MG;0.4MG ** ** Up 2 -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.